In what Boston University President Robert A. Brown envisions as a model for industry and academia collaborating to improve human health, BU has launched a five-year translational research alliance with Johnson & Johnson Innovation LLC (JJI) aimed at preventing, intercepting, and curing lung cancer, the leading cause of cancer deaths worldwide.
As part of the new alliance, Johnson & Johnson Innovation will fund a Johnson & Johnson Innovation Lung Cancer Center at Boston University on the Medical Campus, where BU researchers will work closely with members of the Lung Cancer Initiative within Johnson & Johnson to develop biomarker-based early-screening tests for lung cancer, as well as therapeutics to arrest or eradicate the disease in its earliest stages. The goal is to combine the resources of healthcare giant J&J with expertise at Boston University to speed the development of interventions and cures.
Read the full article here